OnKure Therapeutics (OKUR) Accumulated Expenses (2020 - 2025)
OnKure Therapeutics' Accumulated Expenses came in at $4.66 million for Q2 2025, up 389.0% from $953,000 a year earlier but down 20.9% from the prior quarter.
Powered by 
Analysis
OnKure Therapeutics (OKUR) Accumulated Expenses (2020 - 2025) Analysis & Trends
At the end of FY2024, OnKure Therapeutics' Accumulated Expenses was $7.03 million, up 92.0% from FY2023.
- Accumulated Expenses carries a four-year compound annual growth rate of 17.6% (FY2020 to FY2024).
- Going back by year, Accumulated Expenses was $3.66 million in FY2023 (-24.2%), $4.83 million in FY2022 (+15.5%), $4.18 million in FY2021 (+13.8%) and $3.67 million in FY2020.
- The five-year range for quarterly Accumulated Expenses is $725,000 (Q3 2024) to $11.59 million (Q2 2023).
- Year-over-year, Accumulated Expenses has increased for three consecutive quarters, with growth averaging 59.6% over the last eight quarters.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q2 2025 (growth of 389.0%), and the weakest in Q3 2024 (a decline of 93.3%).
- Business Quant data shows OKUR's Accumulated Expenses at $5.9 million (Q1 2025), $7.03 million (Q4 2024) and $725,000 (Q3 2024) in the three quarters before Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | OnKure Therapeutics | 125.92 Mn | -372.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 4.66 Mn |
| Mar 31, 2025 | 5.90 Mn |
| Dec 31, 2024 | 7.03 Mn |
| Sep 30, 2024 | 725,000.00 |
| Jun 30, 2024 | 953,000.00 |
| Mar 31, 2024 | 1.81 Mn |
| Dec 31, 2023 | 3.66 Mn |
| Sep 30, 2023 | 10.77 Mn |
| Jun 30, 2023 | 11.59 Mn |
| Mar 31, 2023 | 8.32 Mn |
| Dec 31, 2022 | 4.83 Mn |
| Sep 30, 2022 | 6.85 Mn |
| Jun 30, 2022 | 6.37 Mn |
| Mar 31, 2022 | 5.89 Mn |
| Dec 31, 2021 | 4.18 Mn |
| Sep 30, 2021 | 5.08 Mn |
| Jun 30, 2021 | 2.90 Mn |
| Mar 31, 2021 | 3.37 Mn |
| Dec 31, 2020 | 3.67 Mn |
API Access
OnKure Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=OKUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "OKUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=OKUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();